InhaleRx Limited (ASX:IRX)
Australia
· Delayed Price · Currency is AUD 0.0250
0.00 (0.00%)
May 8, 2025, 4:10 PM AEST
InhaleRx Balance Sheet
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Cash & Equivalents | 0.19 | 0.72 | 2.13 | 2.8 | 1.72 | Upgrade
|
| Cash & Short-Term Investments | 0.19 | 0.72 | 2.13 | 2.8 | 1.72 | Upgrade
|
| Cash Growth | -72.77% | -66.45% | -23.90% | 63.04% | 304.66% | Upgrade
|
| Other Receivables | 0.45 | 0.8 | 0.03 | 0.02 | 0.07 | Upgrade
|
| Receivables | 0.45 | 0.8 | 0.03 | 0.02 | 0.07 | Upgrade
|
| Inventory | - | - | - | 0.02 | - | Upgrade
|
| Prepaid Expenses | 0.07 | 0.06 | 0.08 | 0.06 | 0.1 | Upgrade
|
| Other Current Assets | - | - | - | 0 | 0 | Upgrade
|
| Total Current Assets | 0.71 | 1.58 | 2.24 | 2.91 | 1.9 | Upgrade
|
| Property, Plant & Equipment | - | - | - | 0.01 | - | Upgrade
|
| Other Intangible Assets | - | - | 0.01 | 0.01 | 0 | Upgrade
|
| Total Assets | 0.71 | 1.58 | 2.26 | 2.93 | 1.9 | Upgrade
|
| Accounts Payable | 0.57 | 0.18 | 0.12 | 0.07 | 0.12 | Upgrade
|
| Accrued Expenses | - | 0 | 0 | - | 0 | Upgrade
|
| Short-Term Debt | 0.03 | 0.56 | - | - | - | Upgrade
|
| Current Unearned Revenue | - | - | - | 0.02 | 0.08 | Upgrade
|
| Other Current Liabilities | 0.17 | 0.17 | 0.23 | 0.16 | 0.37 | Upgrade
|
| Total Current Liabilities | 0.78 | 0.91 | 0.36 | 0.25 | 0.58 | Upgrade
|
| Total Liabilities | 0.78 | 0.91 | 0.36 | 0.25 | 0.58 | Upgrade
|
| Common Stock | 14.53 | 14.08 | 13.93 | 12.9 | 10.45 | Upgrade
|
| Retained Earnings | -14.38 | -13.17 | -11.73 | -9.25 | -8.14 | Upgrade
|
| Comprehensive Income & Other | -0.21 | -0.24 | -0.3 | -0.97 | -0.99 | Upgrade
|
| Shareholders' Equity | -0.06 | 0.67 | 1.9 | 2.68 | 1.32 | Upgrade
|
| Total Liabilities & Equity | 0.71 | 1.58 | 2.26 | 2.93 | 1.9 | Upgrade
|
| Total Debt | 0.03 | 0.56 | - | - | - | Upgrade
|
| Net Cash (Debt) | 0.16 | 0.16 | 2.13 | 2.8 | 1.72 | Upgrade
|
| Net Cash Growth | 3.41% | -92.71% | -23.90% | 63.04% | 304.66% | Upgrade
|
| Net Cash Per Share | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | Upgrade
|
| Filing Date Shares Outstanding | 213.45 | 189.77 | 187.27 | 168.47 | 134.77 | Upgrade
|
| Total Common Shares Outstanding | 213.45 | 189.77 | 187.27 | 168.47 | 134.77 | Upgrade
|
| Working Capital | -0.06 | 0.67 | 1.89 | 2.65 | 1.32 | Upgrade
|
| Book Value Per Share | -0.00 | 0.00 | 0.01 | 0.02 | 0.01 | Upgrade
|
| Tangible Book Value | -0.06 | 0.67 | 1.89 | 2.66 | 1.32 | Upgrade
|
| Tangible Book Value Per Share | -0.00 | 0.00 | 0.01 | 0.02 | 0.01 | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.